Back to search

University of British Columbia

Improved delivery of Porphyrin derivatives to identified targets

Abstract

dc:description

The thesis is in three parts. Initially, work centred on the development of conjugation technology for covalently binding the photosensitizer (PS) benzoporphyrin derivative monoacid ring A (BPD) to monoclonal antibodies (MoAbs) using a water soluble carrier molecule, modified poiyvinyi alcohol (M-PVA). This conjugation procedure has been shown to be reliable and reproducible and result in negligible loss of biological activity of both MoAb and PS. The second part of the thesis was focused on determining the specificity and selectivity of the MoAb-PS conjugate in an In vitro system. The 5E8 MoAb, specific for human squamous cell lung cancer (A549), was used in this study. Extensive studies in which the 5E8-M-PVA-BPD conjugate was tested and compared with an irrelevant control conjugate - T48-M-PVA-BPD under a variety of experimental conditions established that the 5E8 conjugate had specificity in terms of binding to A549 cells, and had significantly (p <0.01) greater efficacy in photodynamic killing in cytotoxicity assays. Further experiments were carried out to determine whether internalization of the BPD enhanced photodynamic killing. The results showed that internalized conjugate had much higher cytotoxicity than did surface associated. This was shown using two different model systems - 5E8 and the C7 antibody which has specificity for human low density lipoprotein (LDL) receptors. The final part of the thesis was involved in determining the fate of MoAb-PS conjugates in yyQ. Studies were carried out in A549 tumor bearing nude mice comparing the biodistribution of 5E8-M-PVA-BPD and T48-M-PVA-BPD. Both conjugates had biodistribution characteristics which distinguished them from free BPD in that they remained in the circulation and most tissues for significantly (p <0.01) longer times than did free BPD. With the exception of the 5E8-M-PVA-BPD conjugate and A549 tumor tissue, levels in all tissues were highest at the 3 h time point following injection of conjugates. In the case of the A549 tumor and the 5E8-M-PVA-BPD conjugate, the highest concentration of BPD was observed between 14 and 24 h following injection. Since the conjugates tested behaved differently from free BPD it was presumed that the material did not dissociate in and that the specific conjugate demonstrated specificity for the A549 tumor in terms of the kinetics of its accumulation in tumor tissue.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Microbiology and Immunology
Grantor dc:publisher
University of British Columbia
Year dc:date
1992

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jiang, Frank Ningjun

Rights

dc:rights
Statement dc:rights
  • For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/3065

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Jiang, Frank Ningjun. Improved delivery of Porphyrin derivatives to identified targets. doctoral thesis, University of British Columbia, 1992. http://hdl.handle.net/2429/3065